MLABNasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends March 31
MESA LABORATORIES INC /CO/
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$123.31+0.83 (+0.67%)
Close on Oct 19, 2026
- Market cap
- $709.87M
- P/E (TTM)
- 145.1
- Dividend yield
- 0.52%
MESA LABORATORIES INC /CO/ revenue by segment
By business segment
| Revenue | Q1 27 | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sterilization and Disinfection Control [Member] | $24.51M | $29.14M | $24.91M | $22.11M | $25.41M | $24.75M | $23.51M | $22.21M | $22.96M | $22.78M | $19.34M | $17.08M | 40.7% | -3.6% |
| Calibration Solutions [Member] | $13.29M | $13.56M | $14.07M | $13.57M | $12.35M | $13.26M | $14.43M | $12.26M | $11.80M | $12.82M | $12.16M | $11.33M | 22.1% | +7.6% |
| Biopharmaceutical Development [Member] | $12.06M | $8.85M | $14.37M | $13.92M | $11.49M | $12.62M | $12.24M | $11.87M | $12.01M | $12.19M | $9.43M | $9.21M | 20.1% | +5.0% |
| Clinical Genomics [Member] | $10.29M | $12.18M | $11.77M | $11.14M | $10.30M | $11.51M | $12.67M | $11.50M | $11.40M | $11.12M | $12.55M | $15.55M | 17.1% | -0.1% |
By product or service
By region
| Revenue | Q1 27 | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $29.74M | $30.06M | $29.89M | $29.30M | $27.65M | $31.20M | $30.48M | $28.08M | $26.86M | $27.19M | $25.60M | $27.07M | 49.5% | +7.6% |
| Other [Member] | $24.96M | $29.61M | $29.59M | $26.12M | $26.47M | $25.89M | $26.04M | $22.37M | $24.75M | $25.37M | $22.94M | $18.56M | 41.5% | -5.7% |
| China | $5.44M | $4.06M | $5.65M | $5.32M | $5.43M | $5.04M | $6.32M | $7.39M | $6.56M | $6.35M | $4.94M | $7.53M | 9.0% | +0.1% |
From the segment and revenue-disaggregation notes of Mesa Laboratories's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.